11/19
11:41 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
01:35 pm
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
11/18
07:12 am
lrmr
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024 [Yahoo! Finance]
Medium
Report
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024 [Yahoo! Finance]
11/18
07:00 am
lrmr
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
Medium
Report
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
11/16
01:39 am
lrmr
Is Larimar Therapeutics (LRMR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
Medium
Report
Is Larimar Therapeutics (LRMR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
11/4
11:43 am
lrmr
Wall Street Analysts Think Larimar (LRMR) Could Surge 192.89%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Larimar (LRMR) Could Surge 192.89%: Read This Before Placing a Bet [Yahoo! Finance]
10/31
08:35 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/30
07:00 am
lrmr
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Medium
Report
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
10/17
09:12 am
lrmr
Companies Like Larimar Therapeutics (NASDAQ:LRMR) Are In A Position To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like Larimar Therapeutics (NASDAQ:LRMR) Are In A Position To Invest In Growth [Yahoo! Finance]
10/16
07:39 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $26.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $26.00 price target on the stock.
10/6
09:32 pm
lrmr
Larimar Therapeutics' Friedreich's Ataxia Approach Could Have Considerable Upside Potential [Seeking Alpha]
Low
Report
Larimar Therapeutics' Friedreich's Ataxia Approach Could Have Considerable Upside Potential [Seeking Alpha]
10/3
08:17 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $22.00 price target on the stock.
10/2
08:08 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
9/19
07:00 am
lrmr
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
Medium
Report
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
9/5
07:50 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) was upgraded by analysts at Baird R W to a "strong-buy" rating.
High
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) was upgraded by analysts at Baird R W to a "strong-buy" rating.
9/4
08:06 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $16.00 price target on the stock.
High
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $16.00 price target on the stock.
8/27
08:00 am
lrmr
Larimar Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Larimar Therapeutics to Participate in Upcoming Investor Conferences